abrdn Life Sciences Investors SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/Aabrdn Life Sciences InvestorsHQL5d

   abrdn Life Sciences Investors 11.34% held

   • First Trust Portfolios LP holds 3,551,582 shares
   • 11.34% of class represented
   • Shared voting power of 73,412 shares

   FIRST TRUST PORTFOLIOS LP, filed by

2. ROUTINE40-17GABRDN AUSTRALIA EQUITY FUND, INC.IAFSep 24

   40-17G filing

   ABRDN ASIA-PACIFIC INCOME FUND, INC., filer · ABERDEEN MUNICIPAL INCOME FUND, filer · +17 more

3. ROUTINENPORT-Pabrdn Life Sciences InvestorsHQLAug 28

   Fund portfolio holdings

4. ROUTINEN-PXabrdn Life Sciences InvestorsHQLAug 21

   Fund proxy voting record

5. ROUTINE4abrdn Life Sciences InvestorsHQLJul 20

   Chris LaVictoire Mahai, insider filing for HQL

   Chris LaVictoire Mahai, reporting

6. ROUTINE3abrdn Life Sciences InvestorsHQLJun 11

   Chris LaVictoire Mahai, new insider at HQL

   Chris LaVictoire Mahai, reporting

7. ROUTINEN-CSRSabrdn Life Sciences InvestorsHQLJun 8

   Fund semiannual report

8. ROUTINENPORT-Pabrdn Life Sciences InvestorsHQLMay 29

   Fund portfolio holdings

9. ROUTINEDEF 14Aabrdn Healthcare InvestorsHQHApr 7

   Proxy statement

   Life Sciences Investors abrdn, filer · abrdn Healthcare Opportunities Fund, filer · +1 more

10. ROUTINESCHEDULE 13G/Aabrdn Life Sciences InvestorsHQLMar 6

    Ownership stake disclosure by FIRST TRUST PORTFOLIOS LP (amended)

    FIRST TRUST PORTFOLIOS LP, filed by

11. ROUTINENPORT-Pabrdn Life Sciences InvestorsHQLFeb 27

    Fund portfolio holdings

12. NOTABLESCHEDULE 13D/Aabrdn Life Sciences InvestorsHQLFeb 23

    Ownership stake disclosure by Saba Capital Management, L.P. (amended)

    Saba Capital Management, L.P., filed by

13. NOTABLESCHEDULE 13D/Aabrdn Life Sciences InvestorsHQLFeb 11

    Ownership stake disclosure by Saba Capital Management, L.P. (amended)

    Saba Capital Management, L.P., filed by

14. NOTABLESCHEDULE 13D/Aabrdn Life Sciences InvestorsHQLJan 8

    Ownership stake disclosure by Saba Capital Management, L.P. (amended)

    Saba Capital Management, L.P., filed by

15. ROUTINE3abrdn Life Sciences InvestorsHQLDec 19, 2025

    Heather Carter Reilly, new insider at HQL

    Heather Carter Reilly, reporting

16. ROUTINE4abrdn Life Sciences InvestorsHQLDec 18, 2025

    Christian Pittard, insider filing for HQL

    Christian Pittard, reporting

17. ROUTINEN-CSRabrdn Life Sciences InvestorsHQLDec 8, 2025

    Fund shareholder report

18. ROUTINEN-CENabrdn Life Sciences InvestorsHQLDec 8, 2025

    N-CEN filing

19. ROUTINENPORT-Pabrdn Life Sciences InvestorsHQLNov 26, 2025

    Fund portfolio holdings

20. NOTABLESCHEDULE 13D/Aabrdn Life Sciences InvestorsHQLNov 24, 2025

    abrdn Life Sciences Investors filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-24

    Saba Capital Management, L.P., filed by

Older filings on EDGAR